Journal of Biomedical Materials Research - Part B Applied Biomaterials, volume 107, issue 4, pages 1150-1158
Development of novel PLGA nanoparticles with co‐encapsulation of docetaxel and abiraterone acetate for a highly efficient delivery into tumor cells
Sokol Mariya B
1
,
Zenin Vladimir A
2
,
Faustova Mariya R
1, 3
,
Belov Alexey V.
4
,
Zhunina Olga A.
1
,
Mollaev Murad D
1, 3
,
Zabolotsky Artur I
1, 3
,
Tereshchenko Oksana G
1
,
Severin Eugen S
1
1
Russian Research Center for Molecular Diagnostics and Therapy 117638 Moscow Russia
|
Publication type: Journal Article
Publication date: 2018-10-03
Quartile SCImago
Q2
Quartile WOS
Q3
Impact factor: 3.4
ISSN: 15524973, 15524981
Biomaterials
Biomedical Engineering
Abstract
Co-encapsulation of abiraterone acetate (AbrA) and docetaxel (Dtx) in polymeric nanoparticles as novel prototypes for prostate cancer treatment combining hormonal and chemotherapy was designed. Nanoparticles (NPs) composed of poly(dl-lactide-co-glycolide) (PLGA) were prepared by single-emulsion solvent evaporation technique and characterized in terms of morphology with atomic force microscopy and transmission electron microscopy. HPLC method for simultaneous determination of AbrA and Dtx encapsulation efficacy was developed. Also differential scanning calorimetry and Fourier-transform infrared spectroscopy were provided. To study the effectiveness of cellular internalization and distribution of NPs with AbrA and Dtx co-encapsulation (NP-AbrA/Dtx), a fluorescence microscopy was utilized. NPs prepared had size 256.3 ±9.4 nm and zeta potential -18.4 ±1.4 mV. Encapsulation efficacy for AbrA was 68.7% and for Dtx was 74.3%. NPs were able to control the AbrA and Dtx release within 24 h. The mathematical model of drug release was performed. The results obtained from confocal microscopy showed the effective accumulation of the NP-AbrA/Dtx in the cytoplasm of cells. Synthesized NPs possessed satisfactory parameters and a biphasic release profile, proceeding by the Fick diffusion mechanism, which provide prolonged release of the drugs and maintenance of their concentration. It was shown that NPs loaded with AbrA and Dtx exhibited a high cytotoxic activity on the LNCaP cell line, similar to the combination of free drugs of AbrA and Dtx, but in contrast to the combination of substances, had a synergistic mechanism of action. Our findings support the potential use of developed NPs in further in vivo studies. © 2018 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 107B: 1150-1158, 2019.
Citations by journals
|
1
2
3
4
|
|
|
International Journal of Molecular Sciences
|
International Journal of Molecular Sciences
4 publications, 12.12%
|
|
European Journal of Medicinal Chemistry
|
European Journal of Medicinal Chemistry
2 publications, 6.06%
|
|
Pharmaceutics
|
Pharmaceutics
2 publications, 6.06%
|
|
Polymers
|
Polymers
2 publications, 6.06%
|
|
Molecules
|
Molecules
1 publication, 3.03%
|
|
Annales Pharmaceutiques Francaises
|
Annales Pharmaceutiques Francaises
1 publication, 3.03%
|
|
Drug development & registration
|
Drug development & registration
1 publication, 3.03%
|
|
Pharmaceutical Chemistry Journal
|
Pharmaceutical Chemistry Journal
1 publication, 3.03%
|
|
Beilstein Journal of Nanotechnology
|
Beilstein Journal of Nanotechnology
1 publication, 3.03%
|
|
Anti-Cancer Agents in Medicinal Chemistry
|
Anti-Cancer Agents in Medicinal Chemistry
1 publication, 3.03%
|
|
Nanomaterials
|
Nanomaterials
1 publication, 3.03%
|
|
Frontiers in Bioengineering and Biotechnology
|
Frontiers in Bioengineering and Biotechnology
1 publication, 3.03%
|
|
Nano Convergence
|
Nano Convergence
1 publication, 3.03%
|
|
Nanotechnology
|
Nanotechnology
1 publication, 3.03%
|
|
Journal of Drug Delivery Science and Technology
|
Journal of Drug Delivery Science and Technology
1 publication, 3.03%
|
|
Experimental and Molecular Pathology
|
Experimental and Molecular Pathology
1 publication, 3.03%
|
|
International Journal of Pharmaceutics
|
International Journal of Pharmaceutics
1 publication, 3.03%
|
|
European Journal of Pharmaceutics and Biopharmaceutics
|
European Journal of Pharmaceutics and Biopharmaceutics
1 publication, 3.03%
|
|
Colloids and Surfaces A: Physicochemical and Engineering Aspects
|
Colloids and Surfaces A: Physicochemical and Engineering Aspects
1 publication, 3.03%
|
|
Drug Development Research
|
Drug Development Research
1 publication, 3.03%
|
|
Nano Letters
|
Nano Letters
1 publication, 3.03%
|
|
Journal of Biomaterials Science, Polymer Edition
|
Journal of Biomaterials Science, Polymer Edition
1 publication, 3.03%
|
|
International Journal of Polymeric Materials and Polymeric Biomaterials
|
International Journal of Polymeric Materials and Polymeric Biomaterials
1 publication, 3.03%
|
|
Pharmaceutical Development and Technology
|
Pharmaceutical Development and Technology
1 publication, 3.03%
|
|
Drug Delivery
|
Drug Delivery
1 publication, 3.03%
|
|
Micromachines
|
Micromachines
1 publication, 3.03%
|
|
Molecular and Cellular Biochemistry
|
Molecular and Cellular Biochemistry
1 publication, 3.03%
|
|
1
2
3
4
|
Citations by publishers
|
2
4
6
8
10
12
|
|
|
Multidisciplinary Digital Publishing Institute (MDPI)
|
Multidisciplinary Digital Publishing Institute (MDPI)
11 publications, 33.33%
|
|
Elsevier
|
Elsevier
8 publications, 24.24%
|
|
Taylor & Francis
|
Taylor & Francis
4 publications, 12.12%
|
|
Springer Nature
|
Springer Nature
3 publications, 9.09%
|
|
Center of Pharmaceutical Analytics Ltd
|
Center of Pharmaceutical Analytics Ltd
1 publication, 3.03%
|
|
Beilstein-Institut
|
Beilstein-Institut
1 publication, 3.03%
|
|
Bentham Science
|
Bentham Science
1 publication, 3.03%
|
|
Frontiers Media S.A.
|
Frontiers Media S.A.
1 publication, 3.03%
|
|
IOP Publishing
|
IOP Publishing
1 publication, 3.03%
|
|
Wiley
|
Wiley
1 publication, 3.03%
|
|
American Chemical Society (ACS)
|
American Chemical Society (ACS)
1 publication, 3.03%
|
|
2
4
6
8
10
12
|
- We do not take into account publications that without a DOI.
- Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
- Statistics recalculated weekly.
{"yearsCitations":{"type":"bar","data":{"show":true,"labels":[2019,2020,2021,2022,2023],"ids":[0,0,0,0,0],"codes":[0,0,0,0,0],"imageUrls":["","","","",""],"datasets":[{"label":"Citations number","data":[2,9,11,6,5],"backgroundColor":["#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6"],"percentage":["6.06","27.27","33.33","18.18","15.15"],"barThickness":null}]},"options":{"indexAxis":"x","maintainAspectRatio":true,"scales":{"y":{"ticks":{"precision":0,"autoSkip":false,"font":{"family":"Montserrat"},"color":"#000000"}},"x":{"ticks":{"stepSize":1,"precision":0,"font":{"family":"Montserrat"},"color":"#000000"}}},"plugins":{"legend":{"position":"top","labels":{"font":{"family":"Montserrat"},"color":"#000000"}},"title":{"display":true,"text":"Citations per year","font":{"size":24,"family":"Montserrat","weight":600},"color":"#000000"}}}},"journals":{"type":"bar","data":{"show":true,"labels":["International Journal of Molecular Sciences","European Journal of Medicinal Chemistry","Pharmaceutics","Polymers","Molecules","Annales Pharmaceutiques Francaises","Drug development & registration","Pharmaceutical Chemistry Journal","Beilstein Journal of Nanotechnology","Anti-Cancer Agents in Medicinal Chemistry","Nanomaterials","Frontiers in Bioengineering and Biotechnology","Nano Convergence","Nanotechnology","Journal of Drug Delivery Science and Technology","Experimental and Molecular Pathology","International Journal of Pharmaceutics","European Journal of Pharmaceutics and Biopharmaceutics","Colloids and Surfaces A: Physicochemical and Engineering Aspects","Drug Development Research","Nano Letters","Journal of Biomaterials Science, Polymer Edition","International Journal of Polymeric Materials and Polymeric Biomaterials","Pharmaceutical Development and Technology","Drug Delivery","Micromachines","Molecular and Cellular Biochemistry"],"ids":[14627,8171,4502,11204,1770,8051,26766,1261,24250,9738,10051,13389,17767,16187,17907,18388,3305,25165,21908,8186,10312,16012,19112,6847,14854,1083,11788],"codes":[0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0],"imageUrls":["\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp","\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp","\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp","\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp","\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/ewwj5yBvA6wToa4jkXRrcDjN2omUCp6UYltwKhS8_medium.webp","\/storage\/images\/resized\/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_medium.webp","\/storage\/images\/resized\/ex6KJoZujZOZFZh7jGfeHauiftuB3CI7iwJVFRDg_medium.webp","\/storage\/images\/resized\/doUaFUZdxUEQjLi1TwZjGHi8HXYNWWSk04dSC6Xh_medium.webp","\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp","\/storage\/images\/resized\/4QWA67eqfcfyOiA8Wk7YnqroHFqQbTsmDJUYTCTg_medium.webp","\/storage\/images\/resized\/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_medium.webp","\/storage\/images\/resized\/LsKy6OnmmmRGcAU6CZgWQvNiP1polbaSLNrN7zqj_medium.webp","\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/bRyGpdm98BkAUYiK1YFNpl5Z7hPu6Gd87gbIeuG3_medium.webp","\/storage\/images\/resized\/iLiQsFqFaSEx6chlGQ5fbAwF6VYU3WWa08hkss0g_medium.webp","\/storage\/images\/resized\/5YZtvLvkPZuc2JHOaZsjCvGSHFCuC3drUwN3YAc5_medium.webp","\/storage\/images\/resized\/5YZtvLvkPZuc2JHOaZsjCvGSHFCuC3drUwN3YAc5_medium.webp","\/storage\/images\/resized\/5YZtvLvkPZuc2JHOaZsjCvGSHFCuC3drUwN3YAc5_medium.webp","\/storage\/images\/resized\/5YZtvLvkPZuc2JHOaZsjCvGSHFCuC3drUwN3YAc5_medium.webp","\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp","\/storage\/images\/resized\/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_medium.webp"],"datasets":[{"label":"","data":[4,2,2,2,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1],"backgroundColor":["#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6"],"percentage":[12.12,6.06,6.06,6.06,3.03,3.03,3.03,3.03,3.03,3.03,3.03,3.03,3.03,3.03,3.03,3.03,3.03,3.03,3.03,3.03,3.03,3.03,3.03,3.03,3.03,3.03,3.03],"barThickness":13}]},"options":{"indexAxis":"y","maintainAspectRatio":false,"scales":{"y":{"ticks":{"precision":0,"autoSkip":false,"font":{"family":"Montserrat"},"color":"#000000"}},"x":{"ticks":{"stepSize":null,"precision":0,"font":{"family":"Montserrat"},"color":"#000000"}}},"plugins":{"legend":{"position":"top","labels":{"font":{"family":"Montserrat"},"color":"#000000"}},"title":{"display":true,"text":"Journals","font":{"size":24,"family":"Montserrat","weight":600},"color":"#000000"}}}},"publishers":{"type":"bar","data":{"show":true,"labels":["Multidisciplinary Digital Publishing Institute (MDPI)","Elsevier","Taylor & Francis","Springer Nature","Center of Pharmaceutical Analytics Ltd","Beilstein-Institut","Bentham Science","Frontiers Media S.A.","IOP Publishing","Wiley","American Chemical Society (ACS)"],"ids":[202,17,18,8,7156,6139,39,208,2075,11,40],"codes":[0,0,0,0,0,0,0,0,0,0,0],"imageUrls":["\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp","\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/5YZtvLvkPZuc2JHOaZsjCvGSHFCuC3drUwN3YAc5_medium.webp","\/storage\/images\/resized\/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_medium.webp","\/storage\/images\/resized\/ewwj5yBvA6wToa4jkXRrcDjN2omUCp6UYltwKhS8_medium.webp","\/storage\/images\/resized\/ex6KJoZujZOZFZh7jGfeHauiftuB3CI7iwJVFRDg_medium.webp","\/storage\/images\/resized\/doUaFUZdxUEQjLi1TwZjGHi8HXYNWWSk04dSC6Xh_medium.webp","\/storage\/images\/resized\/4QWA67eqfcfyOiA8Wk7YnqroHFqQbTsmDJUYTCTg_medium.webp","\/storage\/images\/resized\/LsKy6OnmmmRGcAU6CZgWQvNiP1polbaSLNrN7zqj_medium.webp","\/storage\/images\/resized\/bRyGpdm98BkAUYiK1YFNpl5Z7hPu6Gd87gbIeuG3_medium.webp","\/storage\/images\/resized\/iLiQsFqFaSEx6chlGQ5fbAwF6VYU3WWa08hkss0g_medium.webp"],"datasets":[{"label":"","data":[11,8,4,3,1,1,1,1,1,1,1],"backgroundColor":["#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6"],"percentage":[33.33,24.24,12.12,9.09,3.03,3.03,3.03,3.03,3.03,3.03,3.03],"barThickness":13}]},"options":{"indexAxis":"y","maintainAspectRatio":false,"scales":{"y":{"ticks":{"precision":0,"autoSkip":false,"font":{"family":"Montserrat"},"color":"#000000"}},"x":{"ticks":{"stepSize":null,"precision":0,"font":{"family":"Montserrat"},"color":"#000000"}}},"plugins":{"legend":{"position":"top","labels":{"font":{"family":"Montserrat"},"color":"#000000"}},"title":{"display":true,"text":"Publishers","font":{"size":24,"family":"Montserrat","weight":600},"color":"#000000"}}}}}
Metrics
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Sokol M. B. et al. Development of novel PLGA nanoparticles with co‐encapsulation of docetaxel and abiraterone acetate for a highly efficient delivery into tumor cells // Journal of Biomedical Materials Research - Part B Applied Biomaterials. 2018. Vol. 107. No. 4. pp. 1150-1158.
GOST all authors (up to 50)
Copy
Sokol M. B., Nikolskaya E. D., Yabbarov N. G., Zenin V. A., Faustova M. R., Belov A. V., Zhunina O. A., Mollaev M. D., Zabolotsky A. I., Tereshchenko O. G., Severin E. S. Development of novel PLGA nanoparticles with co‐encapsulation of docetaxel and abiraterone acetate for a highly efficient delivery into tumor cells // Journal of Biomedical Materials Research - Part B Applied Biomaterials. 2018. Vol. 107. No. 4. pp. 1150-1158.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1002/jbm.b.34208
UR - https://doi.org/10.1002%2Fjbm.b.34208
TI - Development of novel PLGA nanoparticles with co‐encapsulation of docetaxel and abiraterone acetate for a highly efficient delivery into tumor cells
T2 - Journal of Biomedical Materials Research - Part B Applied Biomaterials
AU - Sokol, Mariya B
AU - Faustova, Mariya R
AU - Zhunina, Olga A.
AU - Zabolotsky, Artur I
AU - Severin, Eugen S
AU - Nikolskaya, Elena D
AU - Belov, Alexey V.
AU - Tereshchenko, Oksana G
AU - Zenin, Vladimir A
AU - Yabbarov, Nikita G
AU - Mollaev, Murad D
PY - 2018
DA - 2018/10/03 00:00:00
PB - Wiley
SP - 1150-1158
IS - 4
VL - 107
SN - 1552-4973
SN - 1552-4981
ER -
Cite this
BibTex
Copy
@article{2018_Sokol,
author = {Mariya B Sokol and Mariya R Faustova and Olga A. Zhunina and Artur I Zabolotsky and Eugen S Severin and Elena D Nikolskaya and Alexey V. Belov and Oksana G Tereshchenko and Vladimir A Zenin and Nikita G Yabbarov and Murad D Mollaev},
title = {Development of novel PLGA nanoparticles with co‐encapsulation of docetaxel and abiraterone acetate for a highly efficient delivery into tumor cells},
journal = {Journal of Biomedical Materials Research - Part B Applied Biomaterials},
year = {2018},
volume = {107},
publisher = {Wiley},
month = {oct},
url = {https://doi.org/10.1002%2Fjbm.b.34208},
number = {4},
pages = {1150--1158},
doi = {10.1002/jbm.b.34208}
}
Cite this
MLA
Copy
Sokol, Mariya B., et al. “Development of novel PLGA nanoparticles with co‐encapsulation of docetaxel and abiraterone acetate for a highly efficient delivery into tumor cells.” Journal of Biomedical Materials Research - Part B Applied Biomaterials, vol. 107, no. 4, Oct. 2018, pp. 1150-1158. https://doi.org/10.1002%2Fjbm.b.34208.